Proof of Concept

Advertisement

cGxPJobs Banner

Sionna Advances SION-451 and SION-2222 Into Phase 2a

WALTHAM, Mass. — September 14, 2026 Sionna Therapeutics, Inc. announced plans to advance its preferred proprietary dual combination of...

By cGxPwire Editor
September 15, 2026

Read More

Advertisement

cGxPJobs

Directory